WHC is still in active development. Read this to understand our approach.
depiction of DKNWSYNQZKUICI-UHFFFAOYSA-N.svg
psychonaut

Amantadine

Verificar en psychonaut

pubchem

Amantadine

Verificar en pubchem

drugmap

Amantadine

Verificar en drugmap

wiki

Amantadine

Verificar en wiki

Data

InChI: InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2

Sinónimos: Tricyclo(3.3.1.1(sup 3.7))decan-1-amine,AB00053414-16,Spectrum3_000291, Symadine,BP-13040,DSSTox_RID_76493,Tricyclo[3.3.1.1^(3,7)]decan-1-amine,tricyclo[3.3.1.1(3,7)]decan-1-ylamine,BRD-K70330367-003-01-2,SBI-0049993.P004,Spectrum2_000081,AMANTADINE [VANDF],adamantan-1-amine,Q409761,AB00514655, BIA4304,1-Amantadine,NSC341865,KBio2_005526,ADAMANTANE,1-AMINO,Tricyclo(3.3.1.1(sup 3,7))decan-1-amine,SCHEMBL2619248,adamantaneamine,Adamantanamine,AmantadineHCl,NCGC00015036-02,ACT02873,BRN 2204333, Tricyclo[3.3.1.1(3,7)]decan-1-amine,AS-14215,CCG-204100,Tricyclo(3.3.1.13,7)decan-1-amine,Tricyclo[3.3.1.13,7]decane-1-amine,KBioGR_000548,Tricyclo(3.3.1.1(3,7))-decan-1-amine,KBio2_000390, Amant,F0001-1962,A838887,1-Adamantamine,768-94-5 (FREE BASE),UNII-BF4C9Z1J53, Amantadine Base, Tricyclo[3.3.1.1~3,7~]decan-1-amine,SDCCGSBI-0049993.P005, Wiregyt,Amantadine,NSC 341865,Adamantylamine,KBioSS_000390,DTXSID8022117,1-Aminotricyclo(3.3.1.1(sup 3,7))decane,CHEBI:2618, Tricyclo[3.3.1.1(sup3,7)]decan-1-amine,SPBio_002273,DSSTox_GSID_22117,BDBM50033369,NSC-341865, ADAMANTANE,1-AMINO, Tricyclo(3.3.1.1(sup 3,7))decan-1-amine,BSPBio_001570,D07441,SY017655,SPBio_000002,SCHEMBL21309814,adamantan-1-ylamine,Gocovri,NCGC00015036-09, Tricyclo(3.3.1.1(3,7))-decan-1-amine, Amantadina,amantadine,Q27453436,768-94-5,GTPL4128,Amantadine Base,NCGC00015036-05,Prestwick1_000407,NCGC00015036-11,NCGC00015036-07, Symmetrel (TN),Amantadina, Tricyclo[3.3.1.1(3,7)]decane-1-amine,tricyclo[3.3.1.1(3,7)]decane-1-amine,NCGC00015036-24,NCGC00162039-01,1-admantaneamine,AB00053414_17,NSC83653, Amantidine, Aminoadamantane, Adamantanamine, Gen-Amantadine,1-adamantanylamine,Prestwick0_000407,AE-641/01634060,BIDD:GT0757,STR04703,ADS-5102, EXP 105-1,AB00053414-14,AKOS000113994,Tricyclo[3.3.1.1(3,7)]decan-1-amine, Adamantylamine,AC-25879, TCMDC-125869,1-Adamantanamin,L000868, Amantadina [INN-Spanish],Tox21_110068_1,CHEMBL660,DB00915,(3R,5S,7s)-Adamantan-1-amine, 1-Aminotricyclo(3.3.1.1(sup 3,7))decane,Amantadina [INN-Spanish],Prestwick2_000407,Tricyclo[3.3.1.13,7]decan-1-amine,Tricyclo[3.3.1.1(sup3,7)]decan-1-amine,1-adamantyl amine,Oprea1_248648,768A945,DivK1c_000815,NCGC00015036-08,1-Adamantylamine,Amantadine (INN), OR14310,AKOS000119324,HMS3604O07, Mantadine,AMANTADINE [WHO-DD],CAS-768-94-5,1-amino-adamantane,Mantadine (Salt/Mix),NCGC00015036-03,Prestwick3_000407,NCGC00015036-13, Amantadine (INN),1-Adamantanamine (purified by sublimation),AMANTADINE [HSDB],DSSTox_CID_2117, Tricyclo[3.3.1.1(3,7)]decan-1-ylamine, Endantadine,adamantane-1-amine, Adamantan-1-ylamine,KBio3_001322,adamantyl amine,Amantadinum [INN-Latin],MFCD00074732,1-Aminoadamantane,NCGC00015036-01,Amantidine,NCGC00015036-06,AKOS015935124,BSPBio_001822,Amant,Symmetrel (Salt/Mix),1-adamantaneamine,AMANTADINE [MART.],AKOS007930692,W-104338,KBio2_002958,1-Adamantamine(1-Aminoadamantane),ZINC968256,HMS1791O12,s5499,Amantadin,SCHEMBL23419027,Spectrum4_000134,C06818,ALBB-013871,HMS3887I19,TCMDC-125869,FT-0607338,Exp-105-1 (Salt/Mix),Amantadine [INN:BAN],HSDB 3202, Adamantan-1-amine,AB01275427-01,tricyclo[3.3.1.1~3,7~]decan-1-amine,EC 212-201-2,Tricyclo[3.3.1.1^3,7]decan-1-amine,NCGC00015036-04,Spectrum5_000772, 1-Adamantanamine (8CI),WLN: L66 B6 A B- C 1B ITJ BZ,IDI1_000815,BF4C9Z1J53,J-650234,BSPBio_000334,Adamant-1-ylamine, Amantadinum, Amantadinum [INN-Latin],SCHEMBL15672299,Tricyclo(3.3.1.1(sup 3.7))decan-1-amine, 1-Adamantamine,NCGC00162039-04,Aminoadamantane,CS-W008656,NCGC00179597-01, Tricyclo[3.3.1.1^3,7]decan-1-amine,NCIOpen2_001059, Amantadine [INN:BAN], 1-Adamantylamine,AMANTADINE [INN],(3s,5s,7s)-Tricyclo[3.3.1.1~3,7~]decan-1-Amine,1-Adamantanamine, 1-Aminoadamantane,AMANTADINE [MI],NINDS_000815, Tricyclo(3.3.1.13,7)decan-1-amine,SCHEMBL21310017, 1-Adamantanamine,HY-B0402,NCGC00162039-02,Lopac0_000004,SCHEMBL20409394,Symadine,SCHEMBL4098,EN300-33893,Pk-merz,Spectrum_000030,HMS1989O12,Adamantan-1-amine,1-Adamantylamine, 97%,EINECS 212-201-2,Adamantamine,Lopac-A-1260,AB00053414_18,BPBio1_000368,NCGC00162039-03, Pk-merz,Tox21_110068,STK298781,Amantadinum,KBio1_000815,BCP09869,BRD-K70330367-003-03-8

Estimated data

Solubilidad: -1.253 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 54.2% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.